Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
162
LTM Revenue n/a
LTM EBITDA n/a
$87.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Limes Schlosskliniken has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Limes Schlosskliniken achieved revenue of $39.9M and an EBITDA of $0.9M.
Limes Schlosskliniken expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Limes Schlosskliniken valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $39.9M | n/a | XXX | XXX | XXX |
Gross Profit | $20.7M | $27.9M | XXX | XXX | XXX |
Gross Margin | 52% | NaN% | XXX | XXX | XXX |
EBITDA | $0.9M | n/a | XXX | XXX | XXX |
EBITDA Margin | 2% | NaN% | XXX | XXX | XXX |
Net Profit | $4.2M | $4.5M | XXX | XXX | XXX |
Net Margin | 11% | NaN% | XXX | XXX | XXX |
Net Debt | $2.0M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Limes Schlosskliniken's stock price is EUR 274 (or $294).
Limes Schlosskliniken has current market cap of EUR 80.3M (or $86.3M), and EV of EUR 81.2M (or $87.2M).
See Limes Schlosskliniken trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$87.2M | $86.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Limes Schlosskliniken has market cap of $86.3M and EV of $87.2M.
Limes Schlosskliniken's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Limes Schlosskliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Limes Schlosskliniken and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $87.2M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpLimes Schlosskliniken's NTM/LTM revenue growth is n/a
Limes Schlosskliniken's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Limes Schlosskliniken's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Limes Schlosskliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Limes Schlosskliniken and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 96% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Limes Schlosskliniken acquired XXX companies to date.
Last acquisition by Limes Schlosskliniken was XXXXXXXX, XXXXX XXXXX XXXXXX . Limes Schlosskliniken acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhere is Limes Schlosskliniken headquartered? | Limes Schlosskliniken is headquartered in Germany. |
How many employees does Limes Schlosskliniken have? | As of today, Limes Schlosskliniken has 162 employees. |
Is Limes Schlosskliniken publicy listed? | Yes, Limes Schlosskliniken is a public company listed on DUS. |
What is the stock symbol of Limes Schlosskliniken? | Limes Schlosskliniken trades under LIK ticker. |
When did Limes Schlosskliniken go public? | Limes Schlosskliniken went public in 2018. |
Who are competitors of Limes Schlosskliniken? | Similar companies to Limes Schlosskliniken include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Limes Schlosskliniken? | Limes Schlosskliniken's current market cap is $86.3M |
Is Limes Schlosskliniken profitable? | Yes, Limes Schlosskliniken is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.